Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion type Assertion NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_head.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion description "[We evaluated potential associations between clinical outcome and PVL presence in both methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) isolates from patients enrolled in two large, multinational phase three clinical trials assessing ceftaroline fosamil for the treatment of cSSSI (the CANVAS 1 and 2 programs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion evidence source_evidence_literature NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion SIO_000772 22623995 NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion wasDerivedFrom befree-20140225 NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion wasGeneratedBy ECO_0000203 NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.